Paul T. Francis

Overview

Best Publications

• The cholinergic hypothesis of Alzheimer’s disease: a review of progress

  Paul T Francis;Alan M Palmer;Michael Snape;Gordon K Wilcock

  2853
  Citations

• Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

  Madhav Thambisetty;Andrew Simmons;Latha Velayudhan;Abdul Hye

  501
  Citations

• Correction: Corrigendum: Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer’s Disease

  Omar Kassaar;Marta Pereira Morais;Suying Xu;Emily L. Adam

  498
  Citations

• Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

  David G. Wilkinson;Paul T. Francis;Elias Schwam;Jennifer Payne-Parrish

  466
  Citations

• Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

  Paul T. Francis;Alan M. Palmer;Neil R. Sims;David M. Bowen

  446
  Citations

• Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

  Yonas E. Geda;Lon S. Schneider;Laura N. Gitlin;David S. Miller

  374
  Citations

• The Interplay of Neurotransmitters in Alzheimer's Disease

  Paul T Francis

  357
  Citations

• Glutamatergic systems in Alzheimer's disease

  Paul T. Francis

  342
  Citations

• Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives

  Paul T. Francis;Neil R. Sims;Andrew W. Procter;David M. Bowen

  331
  Citations

• Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease

  M. Garcia-Alloza;F.J. Gil-Bea;M. Diez-Ariza;C.P.L.-H. Chen

  307
  Citations

• Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

  A. M. Palmer;P. T. Francis;J. S. Benton;N. R. Sims

  285
  Citations

• Noradrenergic changes, aggressive behavior, and cognition in patients with dementia

  Kim L Matthews;Christopher P.L.-H Chen;Margaret M Esiri;Janet Keene

  263
  Citations

• Metals ions and neurodegeneration

  Francisco Molina-Holgado;Robert C. Hider;Alessandra Gaeta;Robert Williams

  259
  Citations

• Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease

  A. W. Procter;A. M. Palmer;P. T. Francis;S. L. Lowe

  254
  Citations

• AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease

  Simon Lovestone;Paul Francis;Iwona Kloszewska;Patrizia Mecocci

  244
  Citations

• Cholinergic deficits contribute to behavioral disturbance in patients with dementia

  Stephen Minger;M M Esiri;B McDonald;J Keene

  235
  Citations

• Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease

  Alan M. Palmer;Gordon K. Wilcock;Margaret M. Esiri;Paul T. Francis

  234
  Citations

• Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

  David R. Howlett;David Whitfield;Mary Johnson;Johannes Attems

  233
  Citations

• Apathy associated with neurocognitive disorders: Recent progress and future directions

  Krista L. Lanctôt;Krista L. Lanctôt;Luis Agüera-Ortiz;Henry Brodaty;Paul T. Francis

  232
  Citations

• Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.

  Erika Bereczki;Rui M. Branca;Paul T. Francis;Joana B. Pereira

  227
  Citations

• Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.

  Sara L. Kirvell;Margaret Esiri;Paul T. Francis

  218
  Citations